Binding specificity of polymyxin B, BPI, LALF, and anti-deep core/lipid a monoclonal antibody to lipopolysaccharide partial structures

Shock

Volumn 15, Issue 2, 2001, Pages 124-129

  Kellogg, Todd A ^a   Lazaron, Victor ^a   Wasiluk, Karen R ^a   Dunn, David L ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Antagonists; DPLA; Endotoxin; LPS; MPLA; Re; Sepsis

Indexed keywords

ANTIINFECTIVE AGENT; ANTILIPOPOLYSACCHARIDE FACTOR (LIMULUS); ANTIMICROBIAL CATIONIC PEPTIDE; BACTERICIDAL PERMEABILITY INCREASING PROTEIN; BOVINE SERUM ALBUMIN; DNA; HORMONE; LIPID A; LIPOPOLYSACCHARIDE; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; PLASMA PROTEIN; POLYMYXIN B;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; LIMULUS; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; SALMONELLA;

AMINO ACID SEQUENCE; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBODIES, MONOCLONAL; ANTIMICROBIAL CATIONIC PEPTIDES; BLOOD PROTEINS; DNA; ENZYME-LINKED IMMUNOSORBENT ASSAY; HORSESHOE CRABS; INVERTEBRATE HORMONES; LIPID A; LIPOPOLYSACCHARIDES; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; POLYMYXIN B; SALMONELLA; SERUM ALBUMIN, BOVINE;

EID: 0035257734     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200115020-00008     Document Type: Article

References (35)

1. Barriere S, Lowry S: An overview of mortality risk prediction in sepsis. Crit Care Med 23:376-393, 1995.
2. Brandtzaeg P: Significance and pathogenesis of septic shock. Curr Top Microbiol Immunol 216:15-37, 1996.
3. Morrison D, Silverstein R, Luchi M, Shnyra A: Structure-function relationships of bacterial endotoxins. Infect Dis Clin NA 13:313-340, 1999.
4. Abello P, Buckman T, Buckley G: Shock and multiple organ failure. In Armstrong D (ed): Free Radicals in Diagnostic Medicine. New York: Plenum Press, 1994, pp 253-268.
5. Weise A, Brandenburg K, Ulmer A, Seydel U, Muller-Loennies S: The dual role of lipopolysaccharide as effector and target molecule. Biol Chem 380:767-784, 1999.
6. Rietschel E, Kirikae T, Schade F, Ulmer A, Holst O, Brade H, Schmidt G, Mamat U, Grimmecke H-D, Kusumoto S, Zahringer U: The chemical structure of bacterial endotoxin in relation to bioactivity. Immunobiology 187:169-190, 1993.
7. Aketagawa J, Miyata T, Ohtsubo S, Nakamura T, Morita T, Hayashida H, Iwanaga S: Primary structure of Limulus anticoagulant anti-lipopolysaccharide factor. J Biol Chem 261:7357-7365, 1986.
8. Elsbach P, Weiss J: Role of the bactericidal/permeability-increasing protein in host defence. Curr Opin Immunol 10:45-49, 1998.
9. Warren H, Glennon M, Wainwright N, Amato S, Black K, Kirsch S, Riveau G, Whyte R, Zapol W, Novitsky T: Binding and neutralization of endotoxin by Limulus anti-lipopolysaccharide factor. Infect Immunol 60: 2506-2513, 1992.
10. Gallay P, Carrel S, Glauser M, Barras C, Ulevitch R, Tobias P, Baumgartner J-D, Heumann D: Purification and characterization of murine lipopolysaccharide-binding protein. Infect Immunol 61:378-383, 1993.
11. Schumann R, Rietschel E, Loppnow H: The role of CD14 and lipopolysaccharide-binding protein (LBP) in the activation of different cell types by endotoxin. Med Microbiol Immunol 183:279-297, 1994.
12. Hoess A, Watson S, Siber G, Liddington R: Crystal structure of an endotoxin-neutralizing protein from the horseshoe crab, Limulus anti-LPS factor, at 1.5 A resolution. EMBO J 12:3351-3356, 1993.
13. Hoess A, Schneider-Mergener J, Liddington R: Identification of the LPS-binding domain of an endotoxin neutralising protein, Limulus anti-LPS factor. Prog Clin Biol Res 392:327-337, 1995.
14. Weiss J, Victor M, Elsbach P: Role of charge and hydrophobic interactions in the action of the bactericidal/permeability-increasing protein of neutrophils on gram-negative bacteria. J Clin Investig 71:540-549, 1983.
15. Kloczewiak M, Black K, Loiselle P, Cavaillon J, Wainwright N: Synthetic peptides that mimic the binding site of horseshoe crab anti-lipopolysaccharide factor. J Infect Dis 170:1490-1497, 1994.
16. Morrison D, Jacobs D: Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides. Immunochemistry 13:813-818, 1976.
17. Rustici A, Velucchi M, Faggioni R, Sironi M, Ghezzi P, Quataert S, Gren B, Porro M: Molecular mapping and detoxification of the lipid A binding site by synthetic peptides. Science 259:361-365, 1993.
18. Rifkind D: Prevention by polymyxin B of endotoxin lethality in mice. J Bacteriol 93:1463-1467, 1967.
19. Craig W, Turner J, Kunin C: Prevention of the generalized Shwartzman reaction and endotoxin lethality by polymyxin B localized in tissues. Infect Immunol 10:287-290, 1974.
20. Ooi C, Weiss J, Doerfler M, Elsbach P: Endotoxin-neutralizing properties of the 25-kD N-terminal fragment and newly isolated 30-kD C-terminal fragment of the 55 to 60-kD bactericidal/permeability-increasing protein of human neutrophils. J Exp Med 174:649-655, 1991.
21. Appelmelk B, Qing A, Heimerhorst E, Maaskant J, Abraham P, Thijs L, MacLaren D: Diversity in lipid A binding ligands: comparison of lipid A monoclonal antibodies with rBPI23. In Levin J (ed): Bacterial Endotoxins: Lipopolysaccharides From Genes to Therapy. New York: Wiley-Liss, 1995, pp 453-463.
22. Garcia C, Saladino R, Thompson C, Hammer B, Parsonnet J, Wainwright N, Novitsky T, Fleisher G, Siber G: Effect of a recombinant endotoxin-neutralizing protein on endotoxin shock in rabbits. Crit Care Med 22: 1211-1218, 1994.
23. Kellogg T, Weiss III C, Johnston J, Wasiluk K, Dunn D: Anti-endotoxin agents share molecular homology within their lipopolysaccharide binding domains. J Surg Res 85:136-141, 1999.
24. Weise A, Brandenburg K, Lindner B, Schromm A, Carroll S, Rietschel E, Seydel U: Mechanisms of action of the bactericidal/permeability-increasing protein BPI on endotoxin and phospholipid monolayers and aggregates. Biochemistry 36:10301-10310, 1997.
25. Schromm A, Brandenburg K, Loppnow H, Zahringer U, Rietschel E, Carroll S, Koch M, Kusumoto S, Seydel U: The charge of endotoxin molecules influences their conformation and IL-6-inducing capacity. J Immunol 161:5464-5471, 1998.
26. Brade L, Brandenburg K, Kuhn H-M, Kusumoto S, Macher I, Rietschel E, Brade H: The immunogenicity and antigenicity of lipid A are influenced by its physicochemical state and environment. Infect Immunol 55:2636-2644, 1987.
27. Wasiluk K, Skubitz K, Gray B: Comparison of granule proteins from human polymorphonuclear leukocytes which are bactericidal toward Pseudomonas aeruginosa. Infect Immunol 59:4193-4200, 1991.
28. Burd R: Evaluation of the binding characteristics and mechanisms of action of anti-lipopolysaccharide monoclonal antibodies. Thesis, Graduate School, Minneapolis, University of Minnesota, 1994, pp 14-25.
29. Bone R, Balk R, Fein A, Perl T, Wenzel R, Reines H, Quenzer R, Iberti T, Macintyre N, Schein R: A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multi-center, randomized, controlled trial. Crit Care Med 23:994-1005, 1995.
30. McCloskey R, Straube R, Sanders C, Smith S, Smith C: Treatment of septic shock with human monoclonal antibody HA-1A: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 121:1-5, 1994.
31. Weiss J, Beckerdite-Quagliata S, Elsbach P: Resistance of gram-negative bacteria to purified bactericidal leukocyte proteins. J Clin Investig 65:619-628, 1980.
32. Dentener M, Francot G, Buurman W: Bactericidal/permeability-increasing protein, a lipopolysaccharide-specific protein on the surface of human peripheral blood monocytes. J Infect Dis 173:252-255, 1996.
33. Nnalue N: All accessible epitopes in the Salmonella lipopolysaccharide core are associated with branch residues. Infect Immunol 67:998-1003, 1999.
34. Helander I, Kilpelainen I, Vaara M: Increased substitution of phosphate groups in lipopolysaccharides and lipid A of the polymyxin-resistant pmrA mutants of Salmonella typhimurium: a 31P-NMR study. Mol Microbiol 11:481-487, 1994.
35. Nummila K, Kilpelainen I, Zahringer U, Vaara M, Helander I: Lipopolysaccharides of polymyxin B-resistant mutants of Escherichia coli are extensively substituted by 2-aminoethyl pyrophosphate and contain aminoarabinose in lipid A. Mol Microbiol 16:271-278, 1995.